UK | pharmaphorum

UK

News

BiVictriX's chief executive Tiffany Thorn

Another AIM defection as BiVictriX plans to delist

The list of UK biotechs deciding to abandon listings on the AIM exchange in the UK just lengthened, after BiVictriX said it wants to cancel its shares and go private.

News

Multiple hands raised against multi-colour background

UK drive for research, trial subjects hits key milestone

More than half a million people in the UK have signed up to participate in studies in response to a campaign launched two years ago to revitalise the country's role as a hub for research.

News

Map showing the East West Rail route that lies at the heart of the Oxford-Cambridge supercluster plan

AZ joins call for new UK PM to back Oxford-Cambridge hub

In a letter to the new UK Prime Minister Keir Starmer, leading figures in industry and academia have called for a plan to turn the Oxford-Cambridge region into the 'crown jewel' of the nati

News

Call goes out for simpler clinical trial regulation in UK

Clinical trials are strictly regulated to ensure patient safety, but the current framework in the UK is stifling early-phase clinical research, making it harder to advance novel therapies t

News

Streeting orders “raw and frank” investigation of NHS

New UK Health Secretary Wes Streeting had only been in post a day before declaring the NHS ‘broken’.

News

New UK Prime Minister Keir Starmer (R), with Cabinet shoo-in Angela Rayner

NHS will take more than one term to fix, says Streeting

While the headlines are all about the Labour landslide in the UK general election this morning, Wes Streeting, who has been shadow health secretary in opposition and may well have the equiv

Another AIM defection as BiVictriX plans to delist

UK drive for research, trial subjects hits key milestone

AZ joins call for new UK PM to back Oxford-Cambridge hub

Call goes out for simpler clinical trial regulation in UK

Streeting orders “raw and frank” investigation of NHS

NHS will take more than one term to fix, says Streeting

Repligen builds in cell therapy with $1.5bn BioLife takeover

Discover a new era of healthcare panel engagement: Grounded ...

UK

Editor's Picks